Amarin Urges Shareholders to Vote Against Sarissa's

The NEW Amarin and NEW Board is On the Right Track – Leading Independent Experts, ISS and Glass Lewis, Agree that Sarissa Representation is Not Warranted ...

Related Keywords

United States ,Ireland ,New Jersey ,Dublin ,Switzerland ,Mark Marmur ,Lisa Defrancesco ,Wilkinson Brimmer Katcher ,Joele Frank ,Ironwood Pharmaceuticals Inc ,Sarissa Misguided Campaign To Remove Amarin ,Aegerion Pharmaceuticals Inc ,Vivus Inc ,Ropes Gray ,Glass Lewis Co ,Nasdaq ,Pharmaceuticals Inc ,Alkermes Plc ,Emmaus Life Sciences Inc ,Novelion Therapeutics Inc ,Medicines Company ,Armata Pharmaceuticals Inc ,Company Board Of Directors ,Regulus Therapeutics Inc ,Investor Relations Amarin Corporation ,Exchange Commission ,Amarin Corporation ,Innoviva Inc ,Corporate Communications ,Institutional Shareholder Services ,Bioverativ Inc ,Goodwin Procter ,Right Track ,Leading Independent Experts ,Glass Lewis ,Sarissa Representation ,Misguided Campaign ,Remove Amarin ,Gain De Facto Board Control Would ,Spread Misinformation ,All Amarin Shareholders ,Self Serving Attempt ,Submit Votes ,General Meeting ,Amarin Board ,Chairman Per ,Morrow Sodali ,Okapi Partners ,Relations Amarin Corporation ,Nandi Rose ,Wilkinson Brimmer ,Emmaus Life Sciences ,Aegerion Pharmaceuticals ,Novelion Therapeutics ,Regulus Therapeutics ,Armata Pharmaceuticals ,Ironwood Pharmaceuticals ,Nasdaq Amrn ,Amarin Corporation Plc ,